Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.4000
-0.0250 (-5.88%)
Aug 14, 2026, 4:36 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 13.82 million as of August 14, 2026. Its market cap has decreased by -18.21% in one year.
Market Cap
13.82M
Enterprise Value
12.63M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
ChartMarket Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 13.82M, a decrease of -85.83%. That is a compound annual growth rate of -34.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 13.82M | -52.33% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 35.33M |
| SkinBioTherapeutics | 26.56M |
| Arecor Therapeutics | 22.47M |
| ImmuPharma | 22.46M |
| IXICO | 16.35M |
| Fusion Antibodies | 13.14M |
| Genflow Biosciences | 11.55M |
| Palatin Technologies | 10.86M |